Table 1 Sample characteristics.

From: Impact of accelerometer epoch summary measure on associations between physical activity and all-cause mortality in Whitehall II and UK Biobank

 

Whitehall II

UK Biobank

n (%)

3733 (100%)

89,848 (100%)

Age, years

68.3 (64.7, 73.8)

63.5 (56.3, 68.6)

White ethnicity

3497 (93.7%)

87,118 (97.0%)

Currently in employment

720 (19.3%)

55,642 (61.9%)

Smoking

  

 Never

1817 (48.7%)

51,363 (57.2%)

 Former

1801 (48.2%)

32,353 (36.0%)

 Current

115 (3.1%)

6132 (6.8%)

Alcohol frequency

 

 Never

115 (3.1%)

5000 (5.6%)

 < 1/month

465 (12.5%)

8431 (9.4%)

 1–3/month

N/A

9767 (10.9%)

 2–4/month

658 (17.6%)

N/A

 1–2/week

N/A

22,572 (25.1%)

 2–3/week

1,003 (26.9%)

N/A

 3–4/week

N/A

23,459 (26.1%)

 4+/week

1492 (40.0%)

20,619 (22.9%)

Avg. sleep duration

 

 < 7 h

1416 (37.9%)

19,669 (21.9%)

 7–8 h

2218 (59.4%)

64,544 (71.8%)

 > 9 h

99 (2.7%)

5635 (6.3%)

No. of prescribed medications*

3 (1, 5)

0 (0, 1)

BMI

  

 < 18.5 kg/m2

45 (1.2%)

487 (0.5%)

 18.5–25 kg/m2

1380 (37.0%)

34,936 (38.9%)

 25–30 kg/m2

1635 (43.8%)

37,147 (41.3%)

 > 30 kg/m2

673 (18.0%)

17,278 (19.2%)

Prevalent disease

 

 CVD*

605 (16.2%)

6287 (7.0%)

 Cancer*

389 (10.4%)

12,610 (14.0%)

 Long-standing illness or disease

N/A

24,777 (27.6%)

 No. of other diseases*

1 (0, 1)

0 (0, 0)

  1. Median (Q1, Q3) or n (%).
  2. *Slight differences in definition between cohorts. See Supplementary Table S1 for details.
  3. BMI Body Mass Index, CVD Cardiovascular Disease0.